Michael J Overman

Associate Professor
Department of Gastrointestinal Medical Oncology, Division of
MD Anderson Cancer Center
United States of America

Professor Gastroenterology
Biography

Degree-Granting Education: 2000: Johns Hopkins School of Medicine, Baltimore, MD, USA, MD, Medicine 1996 :Brown University, Providence, RI, USA, BS, Biochemistry 1995 :Kings College, London, GBR, Semester Abroad Program, English and Biology Honors & Awards: 2007 :GI Symposium American Society of Clinical Oncology Merit Award Winner 2003 :Chief Resident Harbor UCLA Internal Medicine 1997 :Johns Hopkins Deans Research Award

Research Intrest

Gastrointestinal Medical Oncology

List of Publications
Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol 122 (1) :146-151, 2017
Fournier K, Rafeeq S, Taggart M, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal R. Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up. Ann Surg Oncol 24 (1) :187-193, 2017
Gulhati P, Raghav K, Shroff RT, Varadhachary GR, Kopetz S, Javle M, Qiao W, Wang H, Morris J, Wolff RA, Overman MJ. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study. Cancer 10 (1002) :1011-1017, 2017